Mary Jane Duermeyer

Title: Mary Jane Duermeyer: Innovator in Cancer Therapy

Introduction

Mary Jane Duermeyer is a prominent inventor based in Glenshaw, PA (US). She has made significant contributions to the field of cancer therapy through her innovative work. With a total of 3 patents, her research focuses on the development of viral vectors that can be utilized in cancer treatment.

Latest Patents

Duermeyer's latest patents include groundbreaking work on recombinant nucleic acids. These nucleic acids comprise one or more polynucleotides encoding immunomodulatory polypeptides, such as human IL-2 or IL-12. The patents detail the viruses that incorporate these recombinant nucleic acids, as well as the compositions and formulations that utilize them. The methods outlined in her patents are aimed at treating various forms of cancer, including lung cancer, and include articles of manufacture or kits for practical application.

Career Highlights

Mary Jane Duermeyer is currently associated with Krystal Biotech, Inc., where she continues to advance her research in cancer therapy. Her work has garnered attention for its potential to improve treatment outcomes for cancer patients.

Collaborations

Duermeyer collaborates with notable colleagues such as Suma Krishnan and Trevor Parry, contributing to a dynamic research environment focused on innovative cancer therapies.

Conclusion

Mary Jane Duermeyer stands out as a key figure in the field of cancer therapy, with her innovative patents paving the way for new treatment methodologies. Her dedication to research and collaboration highlights the importance of innovation in addressing critical health challenges.